Stanislovas S. Jankauskas

SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights From Frail Hypertensive and Diabetic Patients

Pasquale Mone, Fahimeh Varzideh, Stanislovas S. Jankauskas et al. · Hypertension · 2022 · 215 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion

Egor Y. Plotnikov, Stanislovas S. Jankauskas, Irina B. Pevzner et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2010 · 118 citations · Full text

Life Sciences, Biochemistry, Cell Biology +14

Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes

Pasquale Mone, Angela Lombardi, Urna Kansakar et al. · Journal of Pharmacology and Experimental Therapeutics · 2022 · 101 citations · Full text

Medicine, Cardiology, Molecular Medicine +17

COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells

Stanislovas S. Jankauskas, Urna Kansakar, Celestino Sardu et al. · Antioxidants · 2023 · 85 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17

Stress Hyperglycemia Drives the Risk of Hospitalization for Chest Pain in Patients With Ischemia and Nonobstructive Coronary Arteries (INOCA)

Pasquale Mone, Angela Lombardi, Luigi Salemme et al. · Diabetes Care · 2022 · 84 citations · Full text

Medicine, Cardiology, Internal Medicine +12